Literature DB >> 24222505

Nonviral delivery for reprogramming to pluripotency and differentiation.

Hyun-Ji Park1, Jisoo Shin, Jin Kim, Seung-Woo Cho.   

Abstract

Nonviral delivery is a promising strategy for cellular reprogramming to produce desired cell types from undifferentiated stem cells or terminally differentiated somatic cells. Nonviral delivery of genes (DNA, RNA), proteins, or peptides has the potential to reprogram somatic cells to pluripotent stem cells or other lineage cells, and to promote the differentiation of stem cells to specific lineages. Various delivery carriers (cationic polymers, lipids, scaffolds, transposons, cell-penetrating peptides), cargos (episomal plasmids, minicircle DNA, small interfering RNAs, microRNAs, proteins, peptides), and method (electroporation) have been reported. In this article, we review recent advances in nonviral delivery approaches for reprogramming cells to pluripotency or lineage specification.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24222505     DOI: 10.1007/s12272-013-0287-z

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells.

Authors:  Zhong-Kai Cui; Jiabing Fan; Soyon Kim; Olga Bezouglaia; Armita Fartash; Benjamin M Wu; Tara Aghaloo; Min Lee
Journal:  J Control Release       Date:  2015-08-21       Impact factor: 9.776

2.  Glutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation.

Authors:  Bogyu Choi; Zhong-Kai Cui; Soyon Kim; Jiabing Fan; Benjamin M Wu; Min Lee
Journal:  J Mater Chem B       Date:  2015-08-21       Impact factor: 6.331

3.  Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.

Authors:  Fatma Visal Okur; İnci Cevher; Cansu Özdemir; Çetin Kocaefe; Duygu Uçkan Çetinkaya
Journal:  Stem Cell Res Ther       Date:  2019-07-17       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.